Supplementary Data 1 from Unique Spectrum of Activating <i>BRAF</i> Alterations in Prostate Cancer

Supplementary Data 1 from Unique Spectrum of Activating <i>BRAF</i> Alterations in Prostate Cancer

<p>Supplementary Data</p>

Saved in:

书目详细资料
主要作者:	Alex Chehrazi-Raffle (17079582) (author)
其他作者:	Hanna Tukachinsky (15030806) (author), Eamon Toye (15925708) (author), Smruthy Sivakumar (15053536) (author), Alexa B. Schrock (15047582) (author), Hannah E. Bergom (15925687) (author), Hedyeh Ebrahimi (17079585) (author), Sumanta Pal (17079588) (author), Tanya Dorff (17079591) (author), Neeraj Agarwal (15021102) (author), Brandon A. Mahal (17079594) (author), Geoffrey R. Oxnard (15047597) (author), Justin Hwang (15925675) (author), Emmanuel S. Antonarakis (14971443) (author)
出版:	2025
主题:	Cancer Therapeutic Research and Development Methods and Technology Computational Methods Gene expression profiling Genitourinary Cancers Prostate cancer Liquid Biopsy Translational Research
标签:	添加标签没有标签, 成为第一个标记此记录!

相似书籍

Supplementary Figure 1 from Unique Spectrum of Activating <i>BRAF</i> Alterations in Prostate Cancer
由: Alex Chehrazi-Raffle (17079582)
出版: (2025)

Supplementary Tables 1 from Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer
由: Nicole Brighi (22752612)
出版: (2025)

Figure 1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Figure 2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Figure 3 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Figure 4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Figure 5 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Figure 6 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Table 1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Supplementary Figure S1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Supplementary Figure S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Supplementary Figure S3 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Supplementary Figure S4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Supplementary Table S1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Supplementary Table S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Supplementary Table S3 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Supplementary Table S4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Supplementary Table S5 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
由: Ruiliang Wang (17333340)
出版: (2025)

Figure 1 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Figure 2 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Figure 3 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Figure 4 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Figure 5 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Figure 6 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Figure 7 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
由: Martin Sjöström (14845882)
出版: (2025)

Supplementary Table S1 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
由: Sofie H. Tolmeijer (15313251)
出版: (2025)

Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
由: Sofie H. Tolmeijer (15313251)
出版: (2025)

Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
由: Sofie H. Tolmeijer (15313251)
出版: (2025)

Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
由: Emil Christensen (15054394)
出版: (2025)

Supplementary Table S2 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
由: Emil Christensen (15054394)
出版: (2025)

Supplementary Table S1 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
由: Navonil De Sarkar (15030509)
出版: (2025)

Supplementary Table S2 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
由: Navonil De Sarkar (15030509)
出版: (2025)

Supplementary Table S3 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
由: Navonil De Sarkar (15030509)
出版: (2025)

Supplementary Table S4 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
由: Navonil De Sarkar (15030509)
出版: (2025)

Supplementary Table S5 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
由: Navonil De Sarkar (15030509)
出版: (2025)

Supplementary Table 1 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
由: Gillian Vandekerkhove (15034089)
出版: (2025)

Supplementary Table 10 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer
由: Gillian Vandekerkhove (15034089)
出版: (2025)